Farid Khan

3.2k total citations · 3 hit papers
35 papers, 1.9k citations indexed

About

Farid Khan is a scholar working on Infectious Diseases, Epidemiology and Health. According to data from OpenAlex, Farid Khan has authored 35 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 16 papers in Epidemiology and 14 papers in Health. Recurrent topics in Farid Khan's work include SARS-CoV-2 and COVID-19 Research (15 papers), Vaccine Coverage and Hesitancy (14 papers) and COVID-19 epidemiological studies (9 papers). Farid Khan is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (15 papers), Vaccine Coverage and Hesitancy (14 papers) and COVID-19 epidemiological studies (9 papers). Farid Khan collaborates with scholars based in United States, United Kingdom and Israel. Farid Khan's co-authors include John M. McLaughlin, David L. Swerdlow, Luis Jódar, Frederick J. Angulo, Eric J. Haas, Sharon Alroy‐Preis, Kaijie Pan, Gabriel Mircus, Jo Southern and Emilia Anis and has published in prestigious journals such as The Lancet, PLoS ONE and PEDIATRICS.

In The Last Decade

Farid Khan

35 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

2021 1.0k citations Eric J. Haas, Frederick J. Angulo et al. The Lancet profile →
Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysis

2022 116 citations John M. McLaughlin, Farid Khan et al. Open Forum Infectious Diseases profile →
Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe

2023 83 citations Timothy L. Wiemken, Farid Khan et al. Scientific Reports profile →

Peers

Farid Khan

HEALT

EPIDE

PRM

Sarah A. Buchan Canada

Sara E. Oliver United States

Gavin Dabrera United Kingdom

Tyra Grove Krause Denmark

A. Danielle Iuliano United States

Natalie Groves United Kingdom

Simon Thelwall United Kingdom

Vennis Hong United States

Elise Tessier United Kingdom

Simon Cottrell United Kingdom

Sarah A. Buchan Canada

Farid Khan

1.3k ×1.1

504 ×0.8

HEALT

307 ×0.6

655 ×1.2

EPIDE

148 ×1.2

PRM

Citations per year, relative to Farid Khan Farid Khan (= 1×) peers Sarah A. Buchan

Countries citing papers authored by Farid Khan

Since Specialization

Citations

This map shows the geographic impact of Farid Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farid Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farid Khan more than expected).

Fields of papers citing papers by Farid Khan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farid Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farid Khan. The network helps show where Farid Khan may publish in the future.

Co-authorship network of co-authors of Farid Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Farid Khan. A scholar is included among the top collaborators of Farid Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farid Khan. Farid Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McGrath, Leah J., Farid Khan, Santiago M. C. Lopez, et al.. (2025). 2023–2024 COVID-19 vaccine uptake among immunocompromised individuals in two US states. Vaccine. 56. 127120–127120. 1 indexed citations

Andersen, Kathleen M., Farid Khan, Peter W. Park, et al.. (2024). Using a data-driven approach to define post-COVID conditions in US electronic health record data. PLoS ONE. 19(4). e0300570–e0300570. 1 indexed citations

Scott, Amie, Wajeeha Ansari, Farid Khan, et al.. (2024). Substantial health and economic burden of COVID-19 during the year after acute illness among US adults at high risk of severe COVID-19. BMC Medicine. 22(1). 46–46. 12 indexed citations

McGrath, Leah J., Mary M. Moran, Tamuno Alfred, et al.. (2023). Clinical outcomes of COVID-19 and influenza in hospitalized children <5 years in the US. Frontiers in Pediatrics. 11. 1261046–1261046. 4 indexed citations

Wiemken, Timothy L., Farid Khan, Laura Puzniak, et al.. (2023). Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe. Scientific Reports. 13(1). 3886–3886. 83 indexed citations breakdown →

Rudolph, Abby E., Farid Khan, Tanya Singh, et al.. (2023). Effectiveness of BNT162b2 BA.4/5 Bivalent mRNA Vaccine Against Symptomatic COVID-19 Among Immunocompetent Individuals Testing at a Large US Retail Pharmacy. The Journal of Infectious Diseases. 229(3). 648–659. 6 indexed citations

Yamana, Teresa K., Marta Galanti, Sen Pei, et al.. (2023). The impact of COVID-19 vaccination in the US: Averted burden of SARS-COV-2-related cases, hospitalizations and deaths. PLoS ONE. 18(4). e0275699–e0275699. 22 indexed citations

McLaughlin, John M., Farid Khan, Elizabeth Begier, et al.. (2022). 2208. Rates of Medically-Attended RSV among US Adults: A Systematic Review and Meta-Analysis. Open Forum Infectious Diseases. 9(Supplement_2). 10 indexed citations

Khan, Farid, Jennifer L. Nguyen, Tanya Singh, et al.. (2022). Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age. JAMA Network Open. 5(12). e2246915–e2246915. 21 indexed citations

10.

Erber, Wilhelm, Farid Khan, Dace Zavadska, et al.. (2021). Effectiveness of TBE vaccination in southern Germany and Latvia. Vaccine. 40(5). 819–825. 19 indexed citations

11.

Haas, Eric J., John M. McLaughlin, Farid Khan, et al.. (2021). Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study. The Lancet Infectious Diseases. 22(3). 357–366. 79 indexed citations

12.

Haas, Eric J., Frederick J. Angulo, John M. McLaughlin, et al.. (2021). Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. The Lancet. 397(10287). 1819–1829. 1042 indexed citations breakdown →

13.

Galanti, Marta, Sen Pei, Teresa K. Yamana, et al.. (2021). Non-pharmaceutical interventions and inoculation rate shape SARS-CoV-2 vaccination campaign success. Epidemiology and Infection. 149. 2 indexed citations

14.

McLaughlin, John M., et al.. (2019). Rates of hospitalization for community-acquired pneumonia among US adults: A systematic review. Vaccine. 38(4). 741–751. 46 indexed citations

15.

Khan, Farid, David L. Swerdlow, Laura J. York, et al.. (2018). 2455. Is Category B Working? Uptake Patterns of Meningococcal Group B Vaccine Among US Adolescents and Young Adults. Open Forum Infectious Diseases. 5(suppl_1). S735–S735. 2 indexed citations

16.

McLaughlin, John, et al.. (2017). Disparities in Uptake of 13-valent Pneumococcal Conjugate Vaccine among Older Adults Following Routine Recommendation in the United States. Open Forum Infectious Diseases. 4(suppl_1). S468–S469. 1 indexed citations

17.

Lee, Elizabeth C., Cécile Viboud, Lone Simonsen, Farid Khan, & Shweta Bansal. (2015). Detecting signals of seasonal influenza severity through age dynamics. BMC Infectious Diseases. 15(1). 587–587. 9 indexed citations

18.

Gog, Julia R., Sébastien Ballesteros, Cécile Viboud, et al.. (2014). Spatial Transmission of 2009 Pandemic Influenza in the US. PLoS Computational Biology. 10(6). e1003635–e1003635. 129 indexed citations

19.

Viboud, Cécile, Vivek Charu, Donald R. Olson, et al.. (2014). Demonstrating the Use of High-Volume Electronic Medical Claims Data to Monitor Local and Regional Influenza Activity in the US. PLoS ONE. 9(7). e102429–e102429. 45 indexed citations

20.

Matthews, Holly, et al.. (2013). Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate. Malaria Journal. 12(1). 359–359. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact